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Background
MicroRNAs (miRNAs) negatively regulate gene expression
and its deregulation is involved in cancer progression. Our
aim was to verify which miRNAs may play a role in breast
cancer progression, especially metastasis.
Materials and methods
MicroRNA expression profiles were generated by microar-
ray analysis (Agilent) of 70 samples from primary breast
tumors with different clinical staging. Data were analyzed
using bioinformatics software (R, Cluster and Tree View),
which allowed sample discrimination (metastatic vs. non
metastatic tumors) by hierarchical clustering of breast can-
cer expression signatures. We performed a second analysis
using the ROC curve method that allowed us to identify
miRNAs with greater predictive potential of malignancy.
Furthermore, by Venn diagram analysis, we were able to
identify 8 miRNAs that were differentially expressed in all
metastatic tumors of different clinical staging, compared
to the primary non-metastatic tumors. SPSS 19 software
was used to generate a Kaplan-Meier curve (p<0.05) to
estimate the disease-specific survival (considering the spe-
cific event such as death by cancer), based on miRNA
expression patterns.
Results
We found four miRNAs previously described as poten-
tially oncogenic (hsa-let-7a, hsa-let-7b, hsa-let-7c and
hsa-miR-21) for breast cancer, being hsa-let7a, hsa-let7b
and hsa-miR-21 under-expressed in the metastatic vs
non-metastatic tumors, and four new miRNAs candidates
for markers of metastasis (has-miR-1308, has-miR-923,
hsa-miR-328, has-miR-494), the first two were over-
expressed while the latest ones were under-expressed in
metastatic vs non-metastatic tumors.
Conclusions
We identified two groups of miRNAs whose expression
level were associated with worse prognosis. These findings
are important for better understanding of the role of
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